NDC 70771-1791 – Sitagliptin

Sitagliptin 50 mg/1 · Tablet · Oral

Human Prescription Drug

Product NDC70771-1791

Product details

Brand name
Sitagliptin
Generic name
Sitagliptin
Labeler
Zydus Lifesciences Limited
Dosage form
Tablet
Route
Oral
Marketing category
NDA AUTHORIZED GENERIC · NDA211566
Marketed since
November 30, 2023
Listing expires
December 31, 2026
Pharmacologic class
Dipeptidyl Peptidase 4 Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Sitagliptin →

Package NDC codes (2)

Package NDCDescriptionSince
70771-1791-330 TABLET in 1 BOTTLE (70771-1791-3)Nov 30, 2023
70771-1791-990 TABLET in 1 BOTTLE (70771-1791-9)Nov 30, 2023

Other Sitagliptin products